# Christian Angermayer

> Christian Angermayer is a seed investor at Enhanced Games backing Financial Services and FinTech. See 46 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Enhanced Games](https://shizune.co/investors/profile/enhanced-games)
- Location: London, United Kingdom
- Total investments: 46
- Last investment: Oct 2025
- Lead investor: 35%
- Last updated: Aug 2026
- LinkedIn: https://uk.linkedin.com/pub/christian-angermayer/64/134/485
- X (Twitter): https://twitter.com/c_angermayer?lang=en
- Website: https://x.com/c_angermayer
- Facebook: https://www.facebook.com/christian.angermayer

Christian Angermayer is a seed investor at Enhanced Games in London focused on Financial Services and FinTech. Christian Angermayer is based out of London, England and is the Co-Founder & Executive Chairman of Enhanced Games. Christian Angermayer attended the University of Bayreuth.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $549k–$20M |
| Series A | $8M–$45M |
| Series B | $4.4M–$125M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Financial Services | 7 | 15% |
| FinTech | 6 | 13% |
| Blockchain | 6 | 13% |
| Life Science | 5 | 11% |
| Biotechnology | 5 | 11% |

72 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 12 | 26% |
| Series A | 9 | 20% |
| Series B | 6 | 13% |
| Angel | 4 | 9% |
| Venture - Series Unknown | 4 | 9% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 13 | 28% |
| United States | 6 | 13% |
| United Kingdom | 6 | 13% |
| Cayman Islands | 2 | 4% |
| Canada | 1 | 2% |

6 countries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Invyted | Invyted is a marketing tool that connects influencers with venues. |  | Seed | Oct 14, 2025 |  |
| Plasma | Plasma is an operational setting that supports payments, real-world assets, and DeFi, with trustless settlement on Bitcoin. | $3.5M | Seed | Oct 18, 2024 |  |
| Enhanced Games | Enhanced Games is the contemporary reinvention of the Olympic Games without drug testing. |  | Seed | Jan 30, 2024 |  |
| nextmarkets | Nextmarkets is dedicated to `helps private investors to operate in a sustainable and better educated manner on the stock exchange.For this purpose, the company developed a very easy-to-use trading platform in which private investors can trade more than 1,000 CFDs on equities , foreign exchange ( forex , FX ), bonds and commodities veryintuitively - via web and mobile apps . It is scientifically proven that more than 80 percent of all private investors fail on the stock market . This has predominantly behavioral economic reasons. | $11M | Venture - Series Unknown | Apr 18, 2023 |  |
| Razor Group | Razor is a global consumer holding company that partners with e-commerce merchants to acquire and scale brands. Razor uses significant growth capital with extensive e-commerce expertise in order to take these acquired merchants to the next stage of development. Razor focuses on specific product categories, long-term value enhancement, andfirst-class customer satisfaction. | $70M | Series C | Dec 20, 2022 |  |
| Alto Neuroscience | Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develophighly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most. | $35M | Series B | Oct 25, 2022 |  |
| Alto Neuroscience | Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develophighly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most. | $35M | Series B | Oct 25, 2022 |  |
| TRIP | TRIP is a CBD brand that sells wellness products infused with adaptogens. Its product offered are Vegan, gluten-free, and no added sugar. | $12M | Series A | Aug 22, 2022 |  |
| Finclusion Group | Finclusion is a FinTech accelerating company that provides financial services and credit products using AI-powered and data-driven lending for fraud prevention and credit granting. The company also offers buy-now-pay-later (BNPL) services, salary advance schemes, loan services, and transactional banking to individuals and SMEs across 5countries—South Africa, Eswatini, Namibia, Kenya, and Tanzania. | $20M | Angel | Jan 18, 2022 |  |
| Finclusion Group | Finclusion is a FinTech accelerating company that provides financial services and credit products using AI-powered and data-driven lending for fraud prevention and credit granting. The company also offers buy-now-pay-later (BNPL) services, salary advance schemes, loan services, and transactional banking to individuals and SMEs across 5countries—South Africa, Eswatini, Namibia, Kenya, and Tanzania. | $20M | Seed | Jan 18, 2022 |  |

10 of 46 investments shown.

## Co-investors
- [redalpine](https://shizune.co/investors/profile/redalpine-venture-partners) — VC Fund, 6 deals together
- [468 Capital](https://shizune.co/investors/profile/468-capital) — VC Fund, 5 deals together
- [Global Founders Capital](https://shizune.co/investors/profile/global-founders-capital) — VC Fund, 5 deals together
- [Korify Capital](https://shizune.co/investors/profile/korify-capital) — VC Fund, 5 deals together
- [Presight Capital](https://shizune.co/investors/profile/presight-capital) — VC Fund, 5 deals together
- [BitStone Capital](https://shizune.co/investors/profile/bitstone-capital) — VC Fund, 4 deals together

## About Enhanced Games

VC Fund

Enhanced Games is the contemporary reinvention of the Olympic Games without drug testing.

1 contacts available at Enhanced Games.

| Name | Title | Profile |
| --- | --- | --- |
| Christian Angermayer | Co-Founder | https://shizune.co/investors/profile/christian-angermayer |

## Similar investors

### Similar industry
- [Casa Verde Capital](https://shizune.co/investors/profile/casa-verde-capital) — VC Fund
- [Poseidon Asset Management](https://shizune.co/investors/profile/poseidon-assetmanagement) — VC Fund
- [Phyto Partners](https://shizune.co/investors/profile/phyto-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Launch Africa](https://shizune.co/investors/profile/launch-africa) — VC Fund
- [Ventures Platform](https://shizune.co/investors/profile/ventures-platform) — VC Fund
- [Women Entrepreneurship for Africa](https://shizune.co/investors/profile/women-entrepreneurship-for-africa) — VC Fund

## Featured in investor lists
- [Health Care Angel Investors in United Kingdom](https://shizune.co/investors/health-care-angel-investors-united-kingdom)
- [Community Angel Investors in United Kingdom](https://shizune.co/investors/community-angel-investors-united-kingdom)
- [Gaming Angel Investors in United Kingdom](https://shizune.co/investors/gaming-angel-investors-united-kingdom)
- [InsurTech Angel Investors](https://shizune.co/investors/insurtech-angel-investors)
- [Cannabis Investors](https://shizune.co/investors/cannabis-investors)
- [Cannabis Angel Investors](https://shizune.co/investors/cannabis-angel-investors)

## FAQ

### What does Christian Angermayer invest in?

Christian Angermayer invests primarily in Financial Services, FinTech and Blockchain startups, most often at Seed and Series A stage. Most of the 46 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Christian Angermayer's check size?

Christian Angermayer typically joins rounds of $549k–$20M at Seed, $8M–$45M at Series A and $4.4M–$125M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Christian Angermayer participates in.

### When did Christian Angermayer last invest?

The most recent investment recorded for Christian Angermayer closed in Oct 2025. Shizune tracks 46 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co